Grifols witnessed a marked improvement in the top-line in H1, driven by an improving plasma supply which has now exceeded the pre-pandemic levels. However, its exorbitantly high gearing – a function of a debt-financed acquisition binge and tough external improvement – continues to spook markets. Nevertheless, moderating pandemic headwinds, a growing plasma collection network, no major near-term debt maturities and promising long-term plasma market fundamentals should drive an even better perform ....
01 Aug 2022
On-track plasma recovery; but high gearing spooks markets
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
On-track plasma recovery; but high gearing spooks markets
- Published:
01 Aug 2022 -
Author:
Amandeep Goyal | Abhishek Raval -
Pages:
4
Grifols witnessed a marked improvement in the top-line in H1, driven by an improving plasma supply which has now exceeded the pre-pandemic levels. However, its exorbitantly high gearing – a function of a debt-financed acquisition binge and tough external improvement – continues to spook markets. Nevertheless, moderating pandemic headwinds, a growing plasma collection network, no major near-term debt maturities and promising long-term plasma market fundamentals should drive an even better perform ....